# Taysha Gene Therapies (stock symbol: TSHA) Logo in transparent PNG and SVG formats

## Taysha Gene Therapies Logo large

### Taysha Gene Therapies Logo large Download PNG (39.26 KB)

![Taysha Gene Therapies Logo large Download PNG (39.26 KB)](/img/orig/TSHA_BIG-390b574d.png)

### Taysha Gene Therapies Logo large Download SVG (9 KB)

![Taysha Gene Therapies Logo large Download SVG (9 KB)](/img/orig/TSHA_BIG-234fb3d9.svg)

## Taysha Gene Therapies Logo icon format

### Taysha Gene Therapies Logo icon format Download PNG (25.74 KB)

![Taysha Gene Therapies Logo icon format Download PNG (25.74 KB)](/img/orig/TSHA-c1cc607d.png)

### Taysha Gene Therapies Logo icon format Download SVG (2.02 KB)

![Taysha Gene Therapies Logo icon format Download SVG (2.02 KB)](/img/orig/TSHA-28e0767c.svg)

## Taysha Gene Therapies Logo large for dark backgrounds

### Taysha Gene Therapies Logo large for dark backgrounds Download PNG (38.18 KB)

![Taysha Gene Therapies Logo large for dark backgrounds Download PNG (38.18 KB)](/img/orig/TSHA_BIG.D-95081e96.png)

### Taysha Gene Therapies Logo large for dark backgrounds Download SVG (9 KB)

![Taysha Gene Therapies Logo large for dark backgrounds Download SVG (9 KB)](/img/orig/TSHA_BIG.D-1e85137f.svg)

## Taysha Gene Therapies Logo icon format for dark backgrounds

### Taysha Gene Therapies Logo icon format for dark backgrounds Download PNG (24.77 KB)

![Taysha Gene Therapies Logo icon format for dark backgrounds Download PNG (24.77 KB)](/img/orig/TSHA.D-b4937be5.png)

### Taysha Gene Therapies Logo icon format for dark backgrounds Download SVG (2.02 KB)

![Taysha Gene Therapies Logo icon format for dark backgrounds Download SVG (2.02 KB)](/img/orig/TSHA.D-553e8792.svg)

## About Taysha Gene Therapies

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments. The company was incorporated in 2019 and is based in Dallas, Texas.

1. Website domain: tayshagtx.com
2. Employees: 178
3. Marketcap: $49.19 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
- [x] ðŸ§¬ Genomics
- [x] ðŸ§¬ Gene therapy
